- Home
- AQST vs LENZ Comparison
AQST vs LENZ Comparison
Compare AQST & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AQST | LENZ |
|---|---|---|
| Founded | 2004 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 809.3M | 852.0M |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AQST | LENZ |
|---|---|---|
| Price | $5.88 | $18.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 4 |
| Target Price | $8.83 | ★ $56.25 |
| AVG Volume (30 Days) | ★ 2.3M | 1.2M |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $43,397,000.00 | $17,500,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $52.69 | $204.72 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $15.70 |
| 52 Week High | $7.55 | $50.40 |
Technical Indicators
Market Signals| Indicator | AQST | LENZ |
|---|---|---|
| Relative Strength Index (RSI) | 44.66 | 29.25 |
| Support Level | $5.61 | $16.30 |
| Resistance Level | $6.44 | $29.02 |
| Average True Range (ATR) | 0.31 | 2.27 |
| MACD | -0.05 | -0.84 |
| Stochastic Oscillator | 16.00 | 14.79 |
Price Performance
Historical ComparisonAbout AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.